L. Pape

Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine.

R. Larson, M. L. Le Beau, J. Vardiman, 1988, Blood.

Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine.

R. Larson, M. L. Le Beau, J. Vardiman, 1988, Blood.

Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.

R. Larson, J. Cunningham, W. Stock, 2011, Blood.

Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients.

K. van Besien, L. Muffly, M. Kocherginsky, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

complete responses to high-dose cytarabine Short remission durations in therapy-related leukemia despite cytogenetic

M. L. Beau, R. Larson, J. Vardiman, 2011 .

Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Advanced Hematologic Malignancies: Unexpected Renal Toxicity

R. Larson, W. Stock, A. Wickrema, 2009 .

Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab (CMA) Conditioning for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Advanced Hematologic Malignancies: Determination of MTD and Outcomes.

R. Larson, W. Stock, A. Wickrema, 2009 .